
ATRA
NGSAtara Biotherapeutics Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Friday 18th July 2025
9.71
+0.43 (4.63%)
Prev Close:9.28
Open:9.3
Bid:9.0
Ask:9.72
52 Week Range
5.0118.71
Volume:54,823
Mkt Cap:55 M
58
MarketXLS Rank ®
Hold
Price Target
$11.17
+15.0%
Financial Statements
ATRA - Cash Flow (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
---|---|---|---|---|---|---|---|---|---|---|
Asset Impairment Charge | -402000.0 | 214000.0 | 147000.0 | 108000.0 | ||||||
Capital Expenditure Reported | 246000.0 | 4 M | 11 M | 5 M | 6 M | 36 M | 20 M | 3 M | 290000.0 | |
Cash Flow From Continuing Investing Activities | 9 M | 124 M | 203 M | 22 M | -121 M | 60 M | -196 M | 100 M | 84 M | -220 M |
Change In Account Payable | 687000.0 | -3 M | -9 M | 9 M | -815000.0 | 4 M | -2 M | 2 M | 981000.0 | 1 M |
Change In Accrued Expense | 215000.0 | 293000.0 | ||||||||
Change In Payables And Accrued Expense | 687000.0 | -3 M | -9 M | 9 M | -815000.0 | 4 M | -2 M | 2 M | 981000.0 | 1 M |
Change In Prepaid Assets | 8 M | -9 M | -998000.0 | -6 M | -784000.0 | -742000.0 | -767000.0 | |||
Change In Working Capital | -6 M | 38 M | -58 M | 52 M | 51 M | 3 M | -5 M | 3 M | 460000.0 | 470000.0 |
Changes In Account Receivables | 33 M | 6 M | -39 M | 264000.0 | -1 M | |||||
Depreciation And Amortization | 5 M | 5 M | 6 M | 9 M | 8 M | 7 M | 4 M | 956000.0 | 383000.0 | 48000.0 |
Financing Cash Flow | 59 M | 2 M | 53 M | 104 M | 428 M | 189 M | 358 M | 20 M | 506000.0 | 259 M |
Gain Loss On Investment Securities | -240000.0 | 792000.0 | 1 M | 2 M | 828000.0 | -1 M | ||||
Gain Loss On Sale Of PPE | -50 M | 21000.0 | 130000.0 | 1 M | ||||||
Income Tax Paid Supplemental Data | 19000.0 | 15000.0 | 10000.0 | 10000.0 | 3000.0 | |||||
Interest Paid Supplemental Data | 335000.0 | 32000.0 | 62000.0 | 50000.0 | 240000.0 | |||||
Issuance Of Capital Stock | 10 M | 24 M | 105 M | 76 M | 55 M | 72 M | 20 M | 600000.0 | 264 M | |
Issuance Of Debt | -892000.0 | -518000.0 | -254000.0 | -389000.0 | -486000.0 | -528000.0 | ||||
Net Business Purchase And Sale | 95 M | |||||||||
Net Common Stock Issuance | 10 M | 24 M | 105 M | 76 M | 55 M | 72 M | 20 M | 600000.0 | 264 M | |
Net Foreign Currency Exchange Gain Loss | 94000.0 | |||||||||
Net Investment Properties Purchase And Sale | 9 M | -84 M | 112 M | 33 M | -116 M | 66 M | -160 M | 120 M | 87 M | -220 M |
Net Investment Purchase And Sale | 9 M | -84 M | 112 M | 33 M | -116 M | 66 M | -160 M | 120 M | 87 M | -220 M |
Net Issuance Payments Of Debt | -892000.0 | -518000.0 | -254000.0 | -389000.0 | -486000.0 | -528000.0 | ||||
Net Long Term Debt Issuance | -892000.0 | -518000.0 | -254000.0 | -389000.0 | -486000.0 | -528000.0 | ||||
Net PPE Purchase And Sale | -246000.0 | -4 M | -11 M | -5 M | -6 M | -36 M | -20 M | -3 M | -290000.0 | |
Other Non-cash Items | 22 M | 46 M | 66 M | 52 M | 60 M | 41 M | 47 M | 26 M | 17 M | 18 M |
Pension And Employee Benefit Expense | -5 M | -6 M | -7 M | 5 M | 6 M | 4 M | 5 M | 2 M | 1 M | 1 M |
Proceeds From Issuance Of Warrants | 354 M | 141 M | ||||||||
Proceeds From Stock Option Exercised | 439000.0 | |||||||||
Purchase Of Investment | -20 M | -84 M | -181 M | -301 M | -426 M | -270 M | -466 M | 13 M | -156 M | -284 M |
Purchase Of PPE | -246000.0 | -4 M | -11 M | -5 M | -6 M | -36 M | -20 M | -3 M | -290000.0 | |
Repayment Of Debt | -892000.0 | -518000.0 | -254000.0 | -389000.0 | -486000.0 | -528000.0 | ||||
Sale Of Business | 95 M | |||||||||
Sale Of Investment | 29 M | 293 M | 334 M | 310 M | 336 M | 306 M | 108 M | 243 M | 64 M | |
Sale Of PPE | 161000.0 | |||||||||
Stock Based Compensation | 27 M | 45 M | 54 M | 54 M | 51 M | 52 M | 34 M | 23 M | 17 M | 10 M |
Begcash | 107 M | 202 M | 76 M | 62 M | 81 M | 48 M | 24 M | 22 M | ||
Capex | -246000.0 | -4 M | -11 M | -5 M | -6 M | -36 M | -20 M | -3 M | -290000.0 | |
Cffcf | 59 M | 2 M | 53 M | 104 M | 428 M | 189 M | 358 M | 20 M | 506000.0 | 259 M |
Cffinv | 9 M | 124 M | 203 M | 22 M | -121 M | 60 M | -196 M | 99 M | 84 M | -220 M |
Cffoa | -69 M | -193 M | -270 M | -221 M | -181 M | -236 M | -180 M | -88 M | -60 M | -37 M |
Chgcash | -811000.0 | -67 M | -14 M | -94 M | 126 M | 14 M | -19 M | 31 M | 24 M | 2 M |
Chginv | -4 M | -8 M | -2 M | |||||||
Chgothca | -1 M | 273000.0 | 2 M | 8 M | -219000.0 | 322000.0 | -314000.0 | 2000.0 | 6000.0 | -61000.0 |
Chgothcl | -33 M | 41 M | -9 M | 37 M | 61 M | -394000.0 | 3 M | 2 M | 215000.0 | |
Chgothwc | -443000.0 | 1 M | 88000.0 | -2 M | 559000.0 | 322000.0 | 211000.0 | |||
Chgpay | 687000.0 | -3 M | -9 M | 9 M | -815000.0 | 4 M | -2 M | 2 M | 981000.0 | 1 M |
Chgrec | 33 M | 6 M | -39 M | 264000.0 | -1 M | |||||
Comstkiss | 10 M | 24 M | 105 M | 76 M | 55 M | 72 M | 20 M | 600000.0 | 264 M | |
Depamor | 5 M | 5 M | 6 M | 9 M | 8 M | 7 M | 4 M | 956000.0 | 383000.0 | 48000.0 |
Effexch | -94000.0 | |||||||||
Endcash | 25 M | -277 M | 93 M | 107 M | 202 M | 76 M | 62 M | 79 M | 48 M | 24 M |
Fcf | -69 M | -193 M | -275 M | -231 M | -185 M | -241 M | -216 M | -108 M | -63 M | -37 M |
Ltdebtpay | -892000.0 | -518000.0 | -254000.0 | -389000.0 | -486000.0 | -528000.0 | ||||
Netinccont | -85 M | -276 M | -228 M | -340 M | -307 M | -291 M | -231 M | -119 M | -79 M | -57 M |
Netothfin | 51 M | 30 M | -1 M | -2 M | -7 M | 285 M | -357000.0 | -94000.0 | -5 M | |
Netothinv | -1 M | -194000.0 | ||||||||
Opcf | -69 M | -193 M | -270 M | -221 M | -181 M | -236 M | -180 M | -88 M | -60 M | -37 M |
Opgainloss | -5 M | -5 M | -57 M | 6 M | 7 M | 4 M | 5 M | 2 M | 1 M | 1 M |
Purchsti | -20 M | -84 M | -181 M | -301 M | -426 M | -270 M | -466 M | 13 M | -156 M | -284 M |
Salesti | 29 M | 293 M | 334 M | 310 M | 336 M | 306 M | 108 M | 243 M | 64 M |